Iwaki & Co. Ltd. | Cash Flow

Fiscal year is December-November. All values JPY Millions.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
1,167
948
670
52
1,647
1,980
Depreciation, Depletion & Amortization
780
867
946
944
759
756
Other Funds
107
2
2
125
-
343
Funds from Operations
1,257
1,482
1,127
1,531
1,546
2,393
Changes in Working Capital
733
1,058
1,322
578
22
737
Net Operating Cash Flow
525
424
2,449
954
1,524
1,656
Capital Expenditures
521
601
556
609
425
Sale of Fixed Assets & Businesses
54
80
1
98
85
Purchase/Sale of Investments
-
94
239
39
330
Net Investing Cash Flow
963
608
338
573
52
Cash Dividends Paid - Total
202
252
202
200
199
Issuance/Reduction of Debt, Net
138
693
1,531
514
89
Net Financing Cash Flow
170
439
1,735
838
720
Net Change in Cash
587
289
376
515
779
Free Cash Flow
150
110
1,911
369
1,120
Net Assets from Acquisitions
502
-
-
-
-
Other Sources
31
37
10
1
-
Change in Capital Stock
-
-
-
-
432
Exchange Rate Effect
-
22
35
58
27
Other Uses
26
30
33
24
43

About Iwaki & Co.

View Profile
Address
4-8-2 Nihonbashi Hon-cho
Tokyo Tokyo 103
Japan
Employees -
Website http://www.iwaki-kk.co.jp
Updated 07/08/2019
Iwaki & Co., Ltd. engages in the manufacture, trade, and wholesale of pharmaceuticals, cosmetics, chemicals, and food products. It operates through the following segments: Medical and Fine Chemical; Health and Beauty Care; Industrial Chemicals; Food; and Others. The Medical and Fine Chemical segment manufactures and sells active pharmaceutical ingredients, medical supplies, and medical equipment.